TABLE 3.
Relationship between patient factors and gastrointestinal candidiasis (n = 37), Kampala, Uganda, March 2017 to December 2017.
| Variable | Observation | Culture result |
p | ||||
|---|---|---|---|---|---|---|---|
| Growth |
No significant growth |
Total | |||||
| n | (%) | n | (%) | ||||
| Age group† | Children (< 18 years) | 5 | 17.2 | 24 | 83.8 | 29 | 0.26 |
| Youth (18–40 years) | 7 | 11.9 | 52 | 88.1 | 59 | - | |
| Adults (41–65 years) | 12 | 12.4 | 85 | 87.6 | 97 | - | |
| Elderly (> 65 years) | 13 | 23.2 | 43 | 76.8 | 56 | - | |
| Sex | Male | 12 | 9.6 | 112 | 90.3 | 124 | 0.01 |
| Female | 25 | 21.4 | 92 | 78.6 | 117 | - | |
| Type of diabetes mellitus | Type 1 | 11 | 13.4 | 71 | 86.6 | 82 | 0.71 |
| Type 2 | 26 | 12.7 | 133 | 83.6 | 159 | - | |
| Fasting blood glucose | Normal | 17 | 16.4 | 117 | 87.3 | 134 | 0.66 |
| Hyperglycaemic (> 6.1 mmol/L) | 20 | 18.7 | 87 | 81.3 | 107 | - | |
| Glycaemic control | Good (< 7.0%) | 2 | 1.2 | 159 | 98.7 | 161 | ≤ 0.001 |
| Poor | 35 | 43.7 | 45 | 56.3 | 80 | - | |
| Antibiotic use† | Yes | 26 | 63.4 | 15 | 36.6 | 41 | ≤ 0.001 |
| None | 11 | 5.5 | 189 | 94.5 | 200 | - | |
| Antifungal use† | Yes | 25 | 71.4 | 10 | 28.6 | 35 | ≤ 0.001 |
| None | 12 | 5.8 | 194 | 94.2 | 206 | - | |
| Corticosteroid use† | Yes | 14 | 77.8 | 4 | 22.2 | 18 | ≤ 0.001 |
| None | 23 | 10.3 | 200 | 89.7 | 223 | - | |
, Use of antibiotics, antifungals or corticosteroids was defined as treatment for more than 2 weeks less than 1 month ago.